Literature DB >> 10448534

Characterization of glycosylphosphatidylinositiol-anchored, secreted, and intracellular vertebrate mono-ADP-ribosyltransferases.

I J Okazaki1, J Moss.   

Abstract

Mono-ADP-ribosylation is a posttranslational modification of proteins in which the ADP-ribose moiety of nicotinamide adenine dinucleotide is transferred to an acceptor amino acid. Five mammalian ADP-ribosyltransferases (ART1--ART5) have been cloned and expression is restricted to tissues such as cardiac and skeletal muscle, leukocytes, brain, and testis. ART1 and ART2 are glycosylphosphatidylinositol (GPI)-anchored ectoenzymes. ART5 appears not to be GPI-linked and may be secreted. In skeletal muscle and lymphocytes, ART1 modifies specific members of the integrin family of adhesion molecules, suggesting that ADP-ribosylation affects cell-matrix or cell-cell interactions. In lymphocytes, ADP-ribosylation of surface proteins is associated with changes in p56lck tyrosine kinase-mediated signaling. The catalytic sites of bacterial toxins and vertebrate transferases have conserved structural features, consistent with a common reaction mechanism. ADP-ribosylation can be reversed by ADP-ribosylarginine hydrolases, resulting in the regeneration of free arginine. Thus, an ADP-ribosylation cycle may play a regulatory role in vertebrate tissues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10448534     DOI: 10.1146/annurev.nutr.19.1.485

Source DB:  PubMed          Journal:  Annu Rev Nutr        ISSN: 0199-9885            Impact factor:   11.848


  19 in total

Review 1.  Sex-specific lung diseases: effect of oestrogen on cultured cells and in animal models.

Authors:  Bosung Shim; Gustavo Pacheco-Rodriguez; Jiro Kato; Thomas N Darling; Martha Vaughan; Joel Moss
Journal:  Eur Respir Rev       Date:  2013-09-01

2.  Purification and molecular cloning of a DNA ADP-ribosylating protein, CARP-1, from the edible clam Meretrix lamarckii.

Authors:  Tsuyoshi Nakano; Yuko Matsushima-Hibiya; Masafumi Yamamoto; Shigeki Enomoto; Yasuko Matsumoto; Yukari Totsuka; Masahiko Watanabe; Takashi Sugimura; Keiji Wakabayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

3.  Emissive Synthetic Cofactors: An Isomorphic, Isofunctional, and Responsive NAD+ Analogue.

Authors:  Alexander R Rovira; Andrea Fin; Yitzhak Tor
Journal:  J Am Chem Soc       Date:  2017-10-27       Impact factor: 15.419

4.  ARTC1-mediated ADP-ribosylation of GRP78/BiP: a new player in endoplasmic-reticulum stress responses.

Authors:  Gaia Fabrizio; Simone Di Paola; Annalisa Stilla; Monica Giannotta; Carmen Ruggiero; Stephan Menzel; Friedrich Koch-Nolte; Michele Sallese; Maria Di Girolamo
Journal:  Cell Mol Life Sci       Date:  2014-10-08       Impact factor: 9.261

5.  Glucagon like-peptide-1 receptor is covalently modified by endogenous mono-ADP-ribosyltransferase.

Authors:  Matjaž Deželak; Aljoša Bavec
Journal:  Mol Biol Rep       Date:  2011-09-08       Impact factor: 2.316

Review 6.  Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going?

Authors:  Paul O Hassa; Sandra S Haenni; Michael Elser; Michael O Hottiger
Journal:  Microbiol Mol Biol Rev       Date:  2006-09       Impact factor: 11.056

7.  ADP-ribosylarginine hydrolase regulates cell proliferation and tumorigenesis.

Authors:  Jiro Kato; Jianfeng Zhu; Chengyu Liu; Mario Stylianou; Victoria Hoffmann; Martin J Lizak; Connie G Glasgow; Joel Moss
Journal:  Cancer Res       Date:  2011-06-22       Impact factor: 12.701

Review 8.  Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury.

Authors:  Katrina Owens; Ji H Park; Rosemary Schuh; Tibor Kristian
Journal:  Transl Stroke Res       Date:  2013-08-10       Impact factor: 6.829

Review 9.  Structure and function of the ARH family of ADP-ribosyl-acceptor hydrolases.

Authors:  Masato Mashimo; Jiro Kato; Joel Moss
Journal:  DNA Repair (Amst)       Date:  2014-04-18

10.  Pharmacokinetics and safety of a single intravenous dose of myo-inositol in preterm infants of 23-29 wk.

Authors:  Dale L Phelps; Robert M Ward; Rick L Williams; Kristi L Watterberg; Abbot R Laptook; Lisa A Wrage; Tracy L Nolen; Timothy R Fennell; Richard A Ehrenkranz; Brenda B Poindexter; C Michael Cotten; Mikko K Hallman; Ivan D Frantz; Roger G Faix; Kristin M Zaterka-Baxter; Abhik Das; M Bethany Ball; T Michael O'Shea; Conra Backstrom Lacy; Michele C Walsh; Seetha Shankaran; Pablo J Sánchez; Edward F Bell; Rosemary D Higgins
Journal:  Pediatr Res       Date:  2013-09-04       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.